Tradestie Institutional Equity Comparison Engine
PLYX vs NSRX โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
NSRX Overall Edge
NSRX Captures Institutional Edge (2โ0 Pillars ยท 7โ1 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Nasus Pharma Ltd. (NSRX) driven by superior Growth & Margin, Momentum & Technical. Fundamentally, PLYX trades at N/M Forward P/E with N/A operating margin (N/A YoY revenue) versus NSRX at N/M Forward P/E and 0.0% operating margin (+0.0% YoY). In options structure, PLYX sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against NSRX sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).
Valuation Winner
Tie
PLYX N/M vs NSRX N/M Fwd P/E
Growth & Margin Winner
NSRX
Op Margin N/A vs 0.0% ยท YoY N/A vs +0.0%
Momentum & Technical Winner
NSRX
1Y -95.7% vs -66.2% ยท 52W Pos 0% vs 8%
Options & Structure Winner
Tie
UNCLASSIFIED (N/A IV) vs UNCLASSIFIED (N/A IV)
PLYX
US Equity
PLYX
Institutional Equity
$1.51
-6.21% 1D
Market Cap
N/A
1M Return
-22.16%
1Y Return
-95.69%
Forward P/E
N/M
Unified AI Score
43.3 / 100
HOLD
Tech 33.0
Fund 52.0
Flow 50.0
Mom 60.0
NSRX
NYSE American
Nasus Pharma Ltd.
Pharmaceutical Preparations
$2.55
-5.56% 1D
Market Cap
$31.6M
1M Return
-16.67%
1Y Return
-66.23%
Forward P/E
N/M
Unified AI Score
45.4 / 100
HOLD
Tech 33.0
Fund 54.0
Flow 50.0
Mom 60.0
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
PLYX -95.69%
NSRX -66.23%
Spread: +42.04 pp (NSRX Lead)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
PLYX TTM Op. Margin: N/A
NSRX TTM Op. Margin: 0.0%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on PLYX vs NSRX. Trailing 12-month operating profitability (PLYX N/A vs NSRX 0.0%) and valuation multiples (PLYX N/M vs NSRX N/M Forward P/E) are benchmarked directly in Pillar 4 below.
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | PLYX | NSRX | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | N/A | $31.6M | Larger Scale | NSRX |
| Trailing P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Forward P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Revenue Growth (YoY) Growth | N/A | +0.0% | Higher Growth | NSRX |
| Operating Margin (TTM) Profitability | N/A | 0.0% | Higher Margin | NSRX |
| Net Profit Margin Profitability | N/A | 0.0% | Higher Margin | NSRX |
| Return on Equity (ROE) Capital Efficiency | N/A | -316.0% | Higher ROE | NSRX |
| 52-Week Range Position Momentum | 0% ($2โ$49) | 8% ($2โ$10) | Stronger Trend | NSRX |
| Beta / 30D Volatility Risk Regime | 1.43ฮฒ ยท 60% Vol | 1.00ฮฒ ยท 69% Vol | Lower Realized Risk | PLYX |
| Unified Institutional Score Composite Signal | 43.3 / 100 (HOLD) | 45.4 / 100 (HOLD) | Higher Composite | NSRX |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full PLYX vs NSRX Buy Guide
PLYX
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
NSRX
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither PLYX nor NSRX registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.